Price T Rowe Associates Inc Mimedx Group, Inc. Transaction History
Price T Rowe Associates Inc
- $816 Billion
- Q1 2024
A detailed history of Price T Rowe Associates Inc transactions in Mimedx Group, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 32,978 shares of MDXG stock, worth $223,920. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32,978
Previous 29,172
13.05%
Holding current value
$223,920
Previous $256,000
0.78%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding MDXG
# of Institutions
218Shares Held
94.7MCall Options Held
221KPut Options Held
77.4K-
Essex Woodlands Management, Inc. The Woodlands, TX28.2MShares$191 Million63.1% of portfolio
-
Black Rock Inc. New York, NY9.17MShares$62.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.92MShares$40.2 Million0.0% of portfolio
-
State Street Corp Boston, MA4.94MShares$33.6 Million0.0% of portfolio
-
Paradigm Capital Management Inc3.91MShares$26.5 Million1.46% of portfolio
About MIMEDX GROUP, INC.
- Ticker MDXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 113,609,000
- Market Cap $771M
- Description
- MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...